92. Evaluation of Producer Cell Line Platform for Production of Oversized AAV-FVIII Vectors

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)32901-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

247. Characterization of Oversized rAAV Vectors for Human FVIII Gene Transfer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

305. Development of a qPCR Based Assay for Assessing Integrity of Oversized AAV Vectors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Doggybone™ DNA: An Advanced Platform for AAV Production

Cell and Gene Therapy Insights
2017English

Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

681. rDNA-AAV Vectors for the Treatment of Phenylketonuria

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

310. Development of Generation X Recombinant AAV Vectors for Human Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

309. Optimization of Dual AAV Vectors for Gene Therapy of Inherited Retinal Diseases

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Engineered AAV Vectors for Improved Central Nervous System Gene Delivery

Neurogenesis
Developmental NeuroscienceDevelopmental Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy